|
 |
|
|
| Breaking News on Laboratory Equipment |
||
|
||
| Daily
Tuesday 18 December 2007 |
 Forward to a colleague |
|
|
Access Full Stories  Harvard Bioscience knocks back Skystone takeover bidHarvard Bioscience has rejected an unsolicited acquisition offer from Skystone Advisors to acquire all outstanding shares of common stock in the life science tools and instrument manufacturer... Read Curiox' mini-bioassay tech to aid cheaper drug development Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research... Read NIH cash for new tools to unravel genome's secrets The technology used to decipher an organism's gene sequence has come on in leaps and bounds this year. So much so that the US National Institutes of Health (NIH) has now released funds to create new tools to analyse... Read Affymetrix simplifies genetic copy number analysis Affymetrix has launched a new analysis tool for determining genetic variations in whole-genome association and cytogenetic studies that is up to 10 times more sensitive than competing software... Read Biomarker detection gets 'sticky' US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials... Read |
|
|||||||||||||||
All News Headlines for: December | November | October |
|||||||||||||||||
|
Related Industry News Excipient market set to change, says report Advances in the pharmaceutical industry are expected to have an impact on pharmaceutical excipients within the next decade, a new report claims... Read Oxford Genome Sciences advances on Amgen deal Oxford Genome Sciences (OGeS) has taken a step closer to shedding its service provider skin and morphing into a pharma firm after entering a new cancer collaboration with Amgen, one of the world's largest biotech... Read Semen fibrils ferry HIV into cells Tiny protein fibres in semen have been found to enhance the ability of HIV to infect cells by up to 100,000 fold and could provide drug developers with a potent new target to tackle the virus... Read Pronova and FMC to develop seaweed-derived capsules Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology... Read
|
|||||||||||||||||
|
|
|
|||
| Forward to a colleague |
|||||
|
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
|
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||
